Proteinase-activated receptor (PAR)-mediated vasorelaxation in pulmonary arteries from normotensive and hypoxic pulmonary hypertensive rats

Pulmonary Pharmacology and Therapeutics

Volumn 17, Issue 2, 2004, Pages 97-103

  Wanstall, Janet C ^a   Gambino, A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Endothelium dependent vasorelaxation; PAR 2 activating peptide; Proteinase activated receptors; Pulmonary artery; Pulmonary hypertension

Indexed keywords

ACETYLCHOLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR; TRYPSIN; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG RESPONSE; HYPOXIA; LUNG ENDOTHELIUM; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; VASODILATATION;

EID: 0842263887     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pupt.2003.11.002     Document Type: Article

References (19)

1. Adnot S., Raffestin B., Eddahibi S., Braquet P., Chabrier P.-E. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J Clin Invest. 87:1991;155-162.
2. Crawley D.E., Zhao L., Giembycz M.A., Liu S., Barnes P.J., Winter R.J.D., Evans T.W. Chronic hypoxia impairs soluble guanylyl cyclase-mediated pulmonary arterial relaxation in the rat. Am J Physiol. 263:1992;L325-L332.
3. Carville C., Raffestin B., Eddahibi S., Blouquit Y., Adnot S. Loss of endothelium-dependent relaxation in proximal pulmonary arteries from rat exposed to chronic hypoxia: effects of in vivo and in vitro supplementation with L-arginine. J Cardiovasc Pharmacol. 22:1993;889-896.
4. Maruyama J., Maruyama K. Impaired nitric oxide-dependent responses and their recovery in hypertensive pulmonary arteries of rats. Am J Physiol. 266:1994;H2476-H2488.
5. Wanstall J.C., Crilley T.K. Relaxation of rat pulmonary artery by adrenomedullin involves endothelium-derived nitric oxide and is attenuated in hypoxic pulmonary hypertension. Phamacol Comm. 7:1996;349-356.
6. Jeffery T.K., Wanstall J.C. Comparison of pulmonary vascular function and structure in early and established hypoxic pulmonary hypertension in rats. Can J Physiol Pharmacol. 79:2001;227-237.
7. Russ R.D., Walker B.R. Maintained endothelium-dependent pulmonary vasodilation following chronic hypoxia in the rat. J Appl Physiol. 74:1993;339-344.
8. Resta T.C., Walker B.R. Chronic hypoxia selectively augments endothelium-dependent pulmonary arterial vasodilation. Am J Physiol. 270:1996;H888-H896.
9. MacFarlane S.R., Seatter M.J., Kanke T., Hunter G.D., Plevin R. Proteinase-activated receptors. Pharmacol Rev. 53:2001;245-282.
10. Sobey C.G., Moffatt J.D., Cocks T.M. Evidence for selective effects of chronic hypertension on cerebral artery vasodilatation to protease-activated receptor-2 activation. Stroke. 30:1999;1933-1941.
11. Wanstall J.C., Hughes I.E., O'Donnell S.R. Reduced relaxant potency of nitroprusside on pulmonary artery preparations taken from rats during the development of hypoxic pulmonary hypertension. Br J Pharmacol. 107:1992;407-413.
12. Wanstall J.C., O'Donnell S.R. Endothelin and 5-hydroxytryptamine on rat pulmonary artery in pulmonary hypertension. Eur J Pharmacol. 176:1990;159-168.
13. Wanstall J.C., O'Donnell S.R. Responses to vasodilator drugs on pulmonary artery preparations from pulmonary hypertensive rats. Br J Pharmacol. 105:1992;152-158.
14. Wanstall J.C., Hughes I.E., O'Donnell S.R. Evidence that nitric oxide from the endothelium attenuates inherent tone in isolated pulmonary arteries from rats with hypoxic pulmonary hypertension. Br J Pharmacol. 114:1995;109-114.
15. Roy S.S., Saifeddine M., Loutzenhiser R., Triggle C.R., Hollenberg M.D. Dual endothelium-dependent vascular activities of proteinase-activated receptor-2-activating peptides: evidence for receptor heterogeneity. Br J Pharmacol. 123:1998;1434-1440.
16. Suzuki J., Twarog B.M. Membrane properties of smooth muscle cells in pulmonary hypertensive rats. Am J Physiol. 242:1982;H907-H915.
17. Murata T., Sato K., Hori M., Ozaki H., Karaki H. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J Biol Chem. 277:2002;44085-44092.
18. Resta T.C., Gonzales R.J., Dail W.G., Sanders T.C., Walker B.R. Selective upregulation of arterial endothelial nitric oxide synthase in pulmonary hypertension. Am J Physiol. 272:1997;H806-H813.
19. Wanstall J.C., Kaye J.A., Gambino A. The in vitro pulmonary vascular effects of FK409 (nitric oxide donor): a study in normotensive and pulmonary hypertensive rats. Br J Pharmacol. 121:1997;280-286.